Compare WEC & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WEC | CNC |
|---|---|---|
| Founded | 1896 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.3B | 32.1B |
| IPO Year | 1995 | 2001 |
| Metric | WEC | CNC |
|---|---|---|
| Price | $118.24 | $64.91 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $120.08 | $46.75 |
| AVG Volume (30 Days) | 2.2M | ★ 3.9M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.81 | 3.11 |
| Revenue | $9,800,100,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $5.63 | $8.31 |
| Revenue Next Year | $6.58 | $1.05 |
| P/E Ratio | $24.36 | ★ $20.81 |
| Revenue Growth | 13.96 | ★ 19.44 |
| 52 Week Low | $102.49 | $25.08 |
| 52 Week High | $119.62 | $66.55 |
| Indicator | WEC | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 66.18 | 62.60 |
| Support Level | $112.14 | $59.90 |
| Resistance Level | N/A | $66.55 |
| Average True Range (ATR) | 2.05 | 2.41 |
| MACD | 0.63 | -0.34 |
| Stochastic Oscillator | 95.37 | 74.66 |
WEC Energy Group's electric and gas utility businesses serve electric and gas customers in Illinois, Michigan, Minnesota, and Wisconsin service territories. The company also owns a 60% stake in American Transmission Co. WEC's asset mix is approximately 49% electric generation and distribution, 32% gas distribution, 10% electric transmission, 7% unregulated renewable energy, and 2% LNG distribution and generation.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.